Development of a novel glycoengineering platform for the rapid production of conjugate vaccines. (2023)

First Author: Abouelhadid S
Attributed to:  Bacterial oligosaccharyltransferase for glycoengineering and vaccine development funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12934-023-02125-y

PubMed Identifier: 37596672

Publication URI: http://europepmc.org/abstract/MED/37596672

Type: Journal Article/Review

Volume: 22

Parent Publication: Microbial cell factories

Issue: 1

ISSN: 1475-2859